Professor | Wenbin Liu | Asia Growth Partners

Upload Avatar (500 x 500)

Name

Wenbin Liu

Contact Information

lwb2002@126.com

Language ability

Chinese, English

Province

Anhui

University/Lab Affiliation and Title	University of Science and Technology of China
Faculty	Mayo Clinic College of Medicine
Academic Background & Achievements	2002/09–2005/06 Master's in Surgery (General Surgery): Anhui Medical University 2008/09–2011/06 Doctorate in Clinical Medicine: Tianjin Medical University
Work Experience	2005/07–2006/11 - Anhui Provincial Hospital, Liver Surgery - Resident Physician 2006/12–2012/11 - Anhui Provincial Hospital, Liver Surgery - Attending Physician 2012/12–2023/10 - The First Affiliated Hospital of USTC, Liver Surgery - Associate Chief Physician 2023/10–Present - The First Affiliated Hospital of USTC, Liver Surgery - Chief Physician

University/Lab Affiliation and Title

University of Science and Technology of China

Faculty

Mayo Clinic College of Medicine

Academic Background & Achievements

Work Experience

2005/07–2006/11 - Anhui Provincial Hospital, Liver Surgery - Resident Physician
2006/12–2012/11 - Anhui Provincial Hospital, Liver Surgery - Attending Physician
2012/12–2023/10 - The First Affiliated Hospital of USTC, Liver Surgery - Associate Chief Physician
2023/10–Present - The First Affiliated Hospital of USTC, Liver Surgery - Chief Physician

Areas of Focus	Basic and clinical research on recurrence and metastasis of hepatocellular carcinoma
Publications	Analysis of the safety and effectiveness of TACE combined with targeted immunotherapy in the treatment of intermediate and advanced hepatocellular carcinoma., Liu W, Xie Z, Shen K, Jiang L, Liu C, Ge Y, Yu J, Jia W, Ma J, Chen H., 2023 Application Effect of ICG Fluorescence Real-Time Imaging Technology in Laparoscopic Hepatectomy., Chen H, Wang Y, Xie Z, Zhang L, Ge Y, Yu J, Zhang C, Jia W, Ma J, Liu W., 2022 Peroxiredoxin 4 suppresses anoikis and augments growth and metastasis of hepatocellular carcinoma cells through the β-catenin/ID2 pathway., Wang W, Shen XB, Huang DB, Jia W, Liu WB, He YF., 2019 Expression of LAMP3 and its correlation with clinicopathologic characteristics and prognosis in hepatocellular carcinoma., Gui Y, Liu WB, Chen H, Ma JL, Li JS., 2018 Knockdown of GTPBP4 inhibits cell growth and survival in human hepatocellular carcinoma and its prognostic significance., Liu WB, Jia WD, Ma JL, et al., 2017

Areas of Focus

Basic and clinical research on recurrence and metastasis of hepatocellular carcinoma

Publications

Analysis of the safety and effectiveness of TACE combined with targeted immunotherapy in the treatment of intermediate and advanced hepatocellular carcinoma., Liu W, Xie Z, Shen K, Jiang L, Liu C, Ge Y, Yu J, Jia W, Ma J, Chen H., 2023
Application Effect of ICG Fluorescence Real-Time Imaging Technology in Laparoscopic Hepatectomy., Chen H, Wang Y, Xie Z, Zhang L, Ge Y, Yu J, Zhang C, Jia W, Ma J, Liu W., 2022
Peroxiredoxin 4 suppresses anoikis and augments growth and metastasis of hepatocellular carcinoma cells through the β-catenin/ID2 pathway., Wang W, Shen XB, Huang DB, Jia W, Liu WB, He YF., 2019
Expression of LAMP3 and its correlation with clinicopathologic characteristics and prognosis in hepatocellular carcinoma., Gui Y, Liu WB, Chen H, Ma JL, Li JS., 2018
Knockdown of GTPBP4 inhibits cell growth and survival in human hepatocellular carcinoma and its prognostic significance., Liu WB, Jia WD, Ma JL, et al., 2017

Hepatocellular Carcinoma Recurrence Metastasis Clinical Research Basic Research Liver Cancer Oncology Tumor Cancer Treatment Medical Research

Shandong Ye - University of Science and Technology of China

Tang Qiqiang - University of Science and Technology of China

Weidong Jia - University of Science and Technology of China

View All

Personal Information